Historical Stock Price
ETFs Holding TEVA »    TEVA Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $8.63 $8.72 $8.61 $8.66 5.40M
12/05/2022 $8.68 $8.78 $8.58 $8.62 5.01M
12/06/2022 $8.60 $8.64 $8.40 $8.55 8.65M
12/07/2022 $8.49 $8.55 $8.39 $8.45 7.94M
12/08/2022 $8.47 $8.48 $8.24 $8.32 13.32M
Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
TEVA historical stock prices picture
Teva Pharmaceutical Industries (TEVA) has the following price history information. Looking back at TEVA historical stock prices for the last five trading days, on December 02, 2022, TEVA opened at $8.63, traded as high as $8.72 and as low as $8.61, and closed at $8.66. Trading volume was a total of 5.40M shares. On December 05, 2022, TEVA opened at $8.68, traded as high as $8.78 and as low as $8.58, and closed at $8.62. Trading volume was a total of 5.01M shares. On December 06, 2022, TEVA opened at $8.60, traded as high as $8.64 and as low as $8.40, and closed at $8.55. Trading volume was a total of 8.65M shares. On December 07, 2022, TEVA opened at $8.49, traded as high as $8.55 and as low as $8.39, and closed at $8.45. Trading volume was a total of 7.94M shares. On December 08, 2022, TEVA opened at $8.47, traded as high as $8.48 and as low as $8.24, and closed at $8.32. Trading volume was a total of 13.32M shares.

TEVA Historical Stock Prices By Date:

TEVA historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Teva Pharmaceutical Industries shares, starting with a $10,000 purchase of TEVA, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 12/11/2012
End date: 12/08/2022
Start price/share: $41.67
End price/share: $8.32
Starting shares: 239.98
Ending shares: 276.48
Dividends reinvested/share: $6.21
Total return: -77.00%
Average Annual Total Return: -13.67%
Starting investment: $10,000.00
Ending investment: $2,300.34
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/11/2012
End date: 12/08/2022
Start price/share: $41.67
End price/share: $8.32
Dividends collected/share: $6.21
Total return: -65.12%
Average Annual Total Return: -10.00%
Starting investment: $10,000.00
Ending investment: $3,487.79
Years: 10.00
Date Close
12/02/2022$8.66
12/05/2022$8.62
12/06/2022$8.55
12/07/2022$8.45
12/08/2022$8.32
TEVA is categorized under the Healthcare sector; below are some other companies in the same sector:

TFX Historical Stock Prices
TGTX Historical Stock Prices
TGX Historical Stock Prices
TH Historical Stock Prices
THC Historical Stock Prices
THLD Historical Stock Prices
THOR Historical Stock Prices
THRX Historical Stock Prices
TKAI Historical Stock Prices
TKMR Historical Stock Prices

Also explore: TEVA shares outstanding history

Email EnvelopeFree TEVA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

TEVA Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.